Latest Technology News

Artrya Limited has signed a significant five-year commercial agreement with Cone Health, marking its third U.S. customer and solidifying its foothold in the American healthcare market with its AI-powered Salix platform.

TG Metals Limited has reported strong drilling results at its Van Uden Gold Project, confirming multiple gold zones and depth extensions to the current resource. The company plans to resume diamond core and reverse circulation drilling in January 2026 to further define the deposit.

Larvotto Resources has initiated underground development at its Hillgrove Antimony-Gold Project, marking a pivotal step toward resuming production with a comprehensive four-year plan.

Axel REE Limited has announced a substantial upgrade to its Caladão Rare Earth Elements and Gallium resource in Brazil, expanding the project’s scale and advancing plans for low-cost in situ leach extraction.

Pearl Gull Iron has completed the sale of its Cockatoo Island Project, receiving $4.5 million in cash, a 4% indirect stake in Crestlink Pty Ltd, and ongoing royalties. The transaction positions the company to pursue new growth opportunities while maintaining exposure to the project’s future upside.

Adisyn Ltd has completed a strategic review, deciding to boost investment in its graphene-based semiconductor arm while exploring options to unlock value from its managed IT services business.

Saluda Medical has received CE certification for its EVA™ Sensing Technology, enabling commercialisation in Europe and recognition in Australia following prior FDA approval. This milestone sets the stage for a broader rollout of its personalised spinal cord stimulation therapy in early 2026.

Lithium Universe Limited has completed the second tranche of its share placement, raising $40,000 and issuing over 56 million listed options, as it pushes forward with lithium refinery projects in Québec and Texas.

Global Uranium and Enrichment Limited (GUE) has registered its scheme booklet with ASIC, detailing the proposed acquisition by Snow Lake Resources Ltd. The independent expert report supports the fairness and reasonableness of the deal, with GUE directors unanimously recommending shareholder approval.

Blue Star Helium has successfully started helium production at its Galactica project in Colorado, positioning itself as America’s newest helium producer with sales targeted for early 2026. The company’s strategic joint venture and low-cost operations underpin a promising growth trajectory amid rising helium and CO₂ demand.

TrivarX has received $3.5 million in second-tranche placement funding, enabling advancement of its innovative Stabl-Im technology for early, non-invasive brain tumour detection. The funding supports manufacturing scale-up and regulatory preparations ahead of a planned Phase 1 clinical trial in 2026.

CONNEQT Health has raised $3.1 million through an institutional placement to fuel growth of its Pulse vascular health device, supported by both new and existing investors including its largest shareholder.